Product Information
HYDROMORPHONE HCL ER 8 MG TAB is a generic product labeled by Trigen Laboratories, LLC, priced at $5.7288 per EA under NDC 13811070110. Its NADAC has been published 299 times since Jan 11, 2017.
FDA first approved this application on Jul 7, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Hydromorphone Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
8 mg/1
Manufacturer
Trigen Laboratories, LLCNDC
13811070110
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205629FDA Approved
7/7/2016
TE Code
AB
On Market Since
9/15/2016
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE HCL ER 8 MG TAB has been published 299 times since Jan 11, 2017, and over the history we have for it it has declined 31.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.7288 per EA |
|---|---|
| All-time high | $9.1937 (Apr 12, 2017) |
| All-time low | $3.0250 (Mar 20, 2024) |
| 52-week high | $7.0165 |
| 52-week low | $5.7288 |
| Median price | $6.4397 |
| Average price | $6.1046 |
| Largest weekly change | -53.2% (Jun 21, 2023) |
| Weeks tracked | 299 |
| Tracking since | Jan 11, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Trigen Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydromorphone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROMORPHONE HCL ER 8 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE HCL ER 8 MG TAB, manufactured by Trigen Laboratories, LLC, is $5.7288 per EA (NDC 13811070110), effective Sep 30, 2026.
How has the price of HYDROMORPHONE HCL ER 8 MG TAB changed over time?
Over the history we have for it, the NADAC for HYDROMORPHONE HCL ER 8 MG TAB has declined 31.8%. It has been tracked across 299 weekly CMS publications since Jan 11, 2017.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE HCL ER 8 MG TAB?
Since Jan 11, 2017, the NADAC for HYDROMORPHONE HCL ER 8 MG TAB has ranged from a low of $3.0250 (Mar 20, 2024) to a high of $9.1937 (Apr 12, 2017), with a median of $6.4397 per EA.
Are there cheaper alternatives to HYDROMORPHONE HCL ER 8 MG TAB?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROMORPHONE 8 MG TABLET, is $0.5609 per EA — about 90% below HYDROMORPHONE HCL ER 8 MG TAB.
Who manufactures HYDROMORPHONE HCL ER 8 MG TAB?
HYDROMORPHONE HCL ER 8 MG TAB (NDC 13811070110) is labeled by Trigen Laboratories, LLC, and CMS classifies it as a generic product.